Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Gastrointestinal side effects, particularly constipation, occur in roughly one-quarter of patients using GLP-1 receptor agonists for weight loss. While this slowing of digestive transit is a normal response to how these medications work, effective management strategies can minimize discomfort and help you stay on your treatment plan. Understanding both prevention and treatment options empowers you to maintain consistency with your semaglutide therapy.

Why GLP-1 Medications Slow Digestion

GLP-1 receptor agonists like semaglutide work by slowing gastric emptying—the rate at which food moves from your stomach into your intestines. This mechanism helps you feel fuller longer and eat less, but it also reduces how quickly your digestive system processes food and waste. The result is constipation, which typically occurs within the first two weeks of starting treatment or after dose increases.

This side effect is dose-dependent and usually improves over time as your body adjusts. However, some patients experience persistent constipation that requires active management. The good news is that constipation from GLP-1 therapy is reversible and does not indicate organ damage—it simply reflects the medication's intended effect on your gut motility.

Hydration and Fiber: Your First Line of Defense

Increasing water intake is one of the most effective and underutilized strategies for managing GLP-1-related constipation. Aim for at least 8–10 glasses of water daily, more if you exercise or live in a dry climate. Adequate hydration softens stool and helps it move through your colon more easily. Many patients find that simply drinking more water resolves mild constipation within days, without needing additional interventions.

Soluble fiber from sources like oats, beans, psyllium husk, and vegetables supports bowel regularity by absorbing water and forming softer stools. However, increase fiber gradually over one to two weeks to avoid bloating or gas, which can be exacerbated by GLP-1 therapy. Pair fiber intake with your increased water consumption for best results. Avoid sudden high-fiber jumps, as they can temporarily worsen digestive discomfort.

Movement and Physical Activity to Restore Bowel Function

Physical activity stimulates intestinal muscle contractions and accelerates transit time, making regular exercise a evidence-based tool for constipation relief. Even 20–30 minutes of moderate-intensity activity most days—walking, swimming, cycling, or strength training—can noticeably improve bowel regularity. Exercise also amplifies the weight loss benefits of your semaglutide therapy, creating a dual benefit for your health outcomes.

Gentle movement after meals is particularly effective; a 10-minute walk following breakfast, lunch, or dinner encourages natural peristalsis. Avoid prolonged sitting, as sedentary time worsens constipation. If you work at a desk, stand and move for 2–3 minutes every hour. These small habit changes, combined with your GLP-1 medication, create an optimal environment for normal bowel function.

Over-the-Counter and Prescription Options for Persistent Constipation

If dietary and lifestyle changes do not resolve constipation after two weeks, over-the-counter stool softeners like docusate or osmotic laxatives such as polyethylene glycol (Miralax) are safe first-line medical options. These work by drawing water into the stool or reducing stool hardness, allowing easier passage. Avoid stimulant laxatives (bisacodyl, senna) initially, as they can cause cramping and may lead to dependency with prolonged use.

For patients with moderate to severe constipation unresponsive to conservative measures, prescription options exist. Lubiprostone and linaclotide are medications that increase intestinal fluid secretion and muscle contractions, directly counteracting GLP-1's slowing effect. Your healthcare provider can evaluate whether these agents are appropriate for your situation. Always discuss new supplements or medications with your PlexusDx provider before starting, as some interactions may occur with your semaglutide therapy.

Meal Timing and Dietary Choices That Support Bowel Health

Eating smaller, more frequent meals rather than three large ones supports digestion and reduces the burden on your slowed gut. Distribute protein intake throughout the day instead of loading it into one meal, as excess protein can worsen constipation. Include foods rich in magnesium—almonds, spinach, pumpkin seeds—which promote natural bowel movements without harsh side effects.

Limit processed foods, dairy products, and high-fat meals, all of which slow transit further when combined with GLP-1 therapy. Prunes, kiwi fruit, and ground flaxseed are evidence-backed foods that stimulate bowel function naturally. Avoid or minimize alcohol and caffeine, as both can dehydrate and worsen constipation. Creating a meal pattern that emphasizes whole foods, adequate hydration, and appropriate fiber sets the foundation for normal digestion despite your medication.

When to Contact Your Provider About Constipation

Mild constipation is expected with GLP-1 therapy and typically resolves with the strategies outlined above. However, contact your healthcare provider if you experience severe abdominal pain, bloody stools, unexplained weight loss beyond your intended weight loss goals, or constipation lasting longer than three weeks despite aggressive management. These symptoms may indicate a more serious condition unrelated to your GLP-1 therapy.

Your PlexusDx provider can evaluate your individual response, assess whether a dose adjustment might help, or recommend prescription options. Some patients benefit from temporary dose pauses or slower dose escalation schedules. Personalized medical guidance ensures you receive the safest and most effective constipation management while continuing to benefit from your semaglutide treatment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does constipation last when starting semaglutide?

Constipation typically appears within the first two weeks of starting semaglutide and often improves within 4–8 weeks as your body adjusts. For some patients, it persists and requires active management with hydration, fiber, and exercise. If constipation continues beyond three weeks, contact your PlexusDx provider.

Is constipation from GLP-1 medications dangerous?

Constipation from GLP-1 therapy is not dangerous in itself—it reflects the medication's intended slowing of gastric emptying. However, severe constipation with intense pain or bloody stools requires medical evaluation to rule out other causes. Most cases respond well to hydration, fiber, and activity adjustments.

Can I take laxatives while on semaglutide from PlexusDx?

Yes, over-the-counter stool softeners and osmotic laxatives like polyethylene glycol are safe to use with semaglutide. Avoid stimulant laxatives as a first choice due to cramping risk. Always inform your PlexusDx provider of any over-the-counter medications you add to your regimen.

Does PlexusDx offer semaglutide, and what is the cost?

PlexusDx offers compounded Semaglutide Injection from licensed 503A compounding pharmacies, starting at $149 per month across all commitment tiers—your dose may need to go up, but your price won't. No insurance is required, and HSA/FSA accounts are eligible. Semaglutide is available in all 50 states.

Can the Precision Peptide Genetic Test predict constipation risk?

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways and 49 peptides, including genetic variants in GLP1R and GIPR that influence how your body responds to GLP-1 therapy. While the test does not directly predict constipation, understanding your individual peptide-pathway genetics helps optimize your personalized treatment plan and may inform side effect management strategies.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves